Bemærk: Kan ikke leveres før jul.
Forventes på lager: 30-09-2024
Focussing on major developments and new technologies, this book provides an overview of the key topics adopted in current epigenetic drug discovery programmes. An ideal resource for researchers with an interest in epigenetic and genetic factors involved in drug discovery, target ID and validation.
| Forlag | Royal Society of Chemistry |
| Type | Bog |
| Format | Hardback |
| Sprog | Engelsk |
| Udgivelsesdato | 30-09-2024 |
| Første udgivelsesår | 2024 |
| Serie | Drug Discovery Series |
| Fagredaktør | Ho Man (AstraZeneca Chan, Cheryl H (University of Toronto Arrowsmith |
| Originalsprog | United Kingdom |
| Sideantal | 696 |
| Indbinding | Hardback |
| Forlag | Royal Society of Chemistry |
| Sideoplysninger | 696 pages |
| Mål | 164 x 242 x 43 |
| ISBN-13 / EAN-13 | 9781837671106 |